Highest-materiality recent filing
Trafalgar Asset Management acquires voting control of Greater Cannabis Company, appoints new CEO
Trafalgar Asset Management purchased 100% of Series A and Series B preferred stock, gaining 96.62% voting power as of June 29, 2026.
GCAN files Series B Preferred Stock giving CEO Aitan Zacharin 51% voting control
Created 1,000 Series B Convertible Preferred Shares with 51% total voting power.
1-for-1500 reverse split effective after close Oct 16, 2025; trading on post-split basis starts Oct 17.
Greater Cannabis implements 1-for-1,500 reverse stock split effective Oct 15, 2025
Outstanding shares reduced from 1,349,888,436 to approximately 900,256.
GCAN issues 100M shares to CEO for $10K deferred salary
CEO Aitan Zacharin received 100,000,000 restricted shares on April 3, 2025.
Greater Cannabis replaces auditor; prior audit includes going concern doubt
Board terminated Olayinka Oyebola & Co. on March 6, 2025; engaged Aloba Awomolo & Partners same day.
Greater Cannabis Co. increases Series A Preferred voting power to 1.76 votes per share
Effective June 13, 2023, amended Articles to increase Series A Preferred voting power to 1.76 votes per share.
GCAN replaces independent auditor Fruci with Olayinka Oyebola & Co effective Jan 25, 2023
Ended engagement of Fruci & Associates II, PLLC as independent auditor on January 25, 2023, approved by board.
GCAN amends convertible note conversion price to $0.001 for up to $100k
Conversion price set at $0.001 per share for up to $100,000 in principal and interest under a $272,500 note.
GCAN extends note maturities to April 2023, obtains default waiver from FFG
Extended maturity of two Convertible Promissory Notes (each $272,500 principal) to April 30, 2023.
GCAN replaces auditor from Studer to Fruci effective August 1, 2021
Engagement of Michael T. Studer CPA P.C. ended August 1, 2021; no disagreements or reportable events reported.
Greater Cannabis general counsel Mark Radom resigns; service agreement terminated
Mark Radom resigned as general counsel effective October 25, 2021, to pursue other opportunities.
Licensing covers novel cannabinoid therapeutic for autism, schizophrenia, Parkinson's, Alzheimer's, and other neuropsychiatric disorders.
Greater Cannabis Company dismisses auditor Studer, appoints Fruci & Associates
Dismissed Michael T. Studer CPA P.C. as independent auditor effective August 1, 2021; no disagreements or reportable events.
Aitan Zacharin resigned from all officer positions effective immediately upon such appointment and agreed to remain as a member of the Board of Directors solely until the expiration of the ten (10) day period required under Rule 14f-1.
On June 29, 2026, Porfirio Sanchez Talavera was appointed as Chief Executive Officer, Chairman of the Board, and a member of the Board of Directors of the Company.
Upon expiration of such period, Mr. Zacharin’s resignation as a director will become effective and Mr. Sanchez Talavera will remain as the sole director of the Company.
Effective immediately after the filing of this report, Mark Radom resigned from his position of general counsel of the Company.
Effective August 19, 2021, David Tavor resigned as a director of the Company.
Max materiality 0.90 · Median 0.55 · Most common event other_material